CTRI/2018/05/013636
Completed
Phase 2
Evaluation of Safety and efficacy of two different unani compound formulations UNIM 401(O) and 403(L) in cases of Daus Sadaf (Psoriasis)
ConditionsHealth Condition 1: null- Psoriasis
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Psoriasis
- Sponsor
- Central Council for Research in Unani Medicine
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Apparent psoriatic lesions of the body.
Exclusion Criteria
- •1\. Patients with psoriatic arthritis
- •2\. Patients suffering with other skin diseases
- •3\. Serious systemic diseases
- •4\. Pregnant and lactating mothers
- •5\. Patient unsure about attending treatment schedule regularly and those who do not have a suitable place for sun exposure.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Treatment of Psoriasis with IPD admissioHealth Condition 1: null- PsoriasisCTRI/2018/05/014152Central Council for Research in Unani Medicine120
Not yet recruiting
Not Applicable
Comparison of different doses of Oxytocin during caesarian deliveryCTRI/2023/07/054979medical Superintendent
Completed
Not Applicable
Effectiveness and safety of a fixed dosed combination of adapalene and clindamycin in the treatment of acne vulgaris.Health Condition 1: null- Acne VulgarisHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissueCTRI/2018/04/013109Investigator Initiated Study
Not yet recruiting
Not Applicable
Clinical study of iron supplement in iron deficiency anemia and fatigueCTRI/2023/01/048783Meyer Organics Pvt Ltd
Active, not recruiting
Not Applicable
A study to compare the efficacy and safety of two different types of Botulinum Toxin Type A (BOTOX or Dysport) in the Treatment of Moderate to Severe Cervical Dystonia - NDEUCTR2006-006449-14-ITALLERGA160